Caris Life Sciences, Inc. (CAI)

NASDAQ: CAI · Real-Time Price · USD

26.78

-0.34 (-1.25%)

At close: Jan 16, 2026, 4:00 PM EST

26.76

-0.02 (-0.07%)

After-hours: Jan 16, 2026, 7:10 PM EST

Caris Life Sciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Net Income	-186.99	-281.89	-341.42	-320.83
Depreciation & Amortization	27.39	48.91	49	48.25
Other Amortization	14.07	7.05	5.38	2.65
Stock-Based Compensation	61.62	18.64	15.24	22.9
Other Operating Activities	64.37	-8.85	2.82	-16.43
Change in Accounts Receivable	42.43	-33.82	-15.08	-11.91
Change in Inventory	-9.9	5.46	-4.44	-11.1
Change in Accounts Payable	-6.48	-0.23	7.17	8.91
Change in Other Net Operating Assets	-7.05	-0.48	5.22	-8.16
Operating Cash Flow	-0.55	-245.2	-276.1	-285.71
Capital Expenditures	-13.46	-8.44	-22.32	-42.26
Investment in Securities	-	61.38	237.09	-240.73
Investing Cash Flow	-13.46	52.93	214.77	-282.99
Long-Term Debt Issued	-	199.98	191.31	-
Long-Term Debt Repaid	-	-0.16	-180.74	-0.96
Net Debt Issued (Repaid)	27.78	199.82	10.57	-0.96
Issuance of Common Stock	532.51	1.53	1.87	11.41
Other Financing Activities	-1.47	-1.06	-2.3	-
Financing Cash Flow	661.82	200.29	10.13	10.45
Foreign Exchange Rate Adjustments	0.16	-0	0.06	0
Net Cash Flow	647.97	8.02	-51.13	-558.25
Free Cash Flow	-14.01	-253.64	-298.42	-327.96
Free Cash Flow Margin	-2.16%	-61.52%	-97.48%	-126.88%
Free Cash Flow Per Share	-0.13	-7.15	-8.54	-9.83
Cash Interest Paid	49.02	49.02	15.78	24.24
Levered Free Cash Flow	-	-143.65	-178.04	-
Unlevered Free Cash Flow	-	-119.44	-163.66	-
Change in Working Capital	19	-29.07	-7.13	-22.26

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q